CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biggs, J. R.
Right arrow Articles by Kraft, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biggs, J. R.
Right arrow Articles by Kraft, A. S.

Cell Growth & Differentiation, Vol 9, Issue 8 667-676, Copyright © 1998 by American Association of Cancer Research


ARTICLES

Activation of the mitogen-activated protein kinase pathway in U937 leukemic cells induces phosphorylation of the amino terminus of the TATA-binding protein

JR Biggs, NG Ahn and AS Kraft
Department of Medical Oncology, University of Colorado Health Sciences Center, Denver 80262, USA.

Phorbol ester treatment of U937 leukemic cells results in the activation of numerous protein kinase pathways, followed by cell cycle arrest and differentiation into macrophage-like cells. Because major changes in gene transcription are associated with this process, the role of general transcription factors in the cell response to phorbol esters was examined. Experiments demonstrate that phorbol ester treatment of U937 cells stimulates the phosphorylation of the TATA-binding protein (TBP); this phosphorylation occurs within 30 min and is still apparent, although greatly reduced, at 4 h. The following results demonstrate that TBP phosphorylation occurs as a result of activation of an extracellular signal-regulated kinase (ERK) protein kinase: (a) overexpression of mitogen-activated protein kinase phosphatase-1 blocks phorbol 12-myristate 13-acetate (PMA)-induced phosphorylation of TBP both in vitro and in vivo; (b) pretreatment with the ERK kinase kinase inhibitor PD098059 also blocks PMA-induced phosphorylation of TBP both in vitro and in vivo; and (c) phosphorylation of TBP is observed when serum-starved NIH 3T3 cells are stimulated with fresh serum, another activator of the ERK pathway. TBP can be phosphorylated in vitro by extracts of U937 cells or by bacterially expressed activated ERK2; the phosphorylation sites were mapped to ERK kinase consensus sites in the TBP amino-terminal domain. Using glutathione S-transferase-TBP fusion proteins, cellular proteins that bind specifically to the TBP amino terminus have been identified. These observations suggest that ERK-mediated phosphorylation of TBP occurs during the PMA-induced differentiation of U937 cells and the stimulation of the G0-G1 transition in fibroblasts and could play a role in the regulation of TBP protein interactions and thus regulate gene transcription during these two processes.


This article has been cited by other articles:


Home page
J Biol ChemHome page
Y. Zhang, J. R. Biggs, and A. S. Kraft
Phorbol Ester Treatment of K562 Cells Regulates the Transcriptional Activity of AML1c through Phosphorylation
J. Biol. Chem., December 17, 2004; 279(51): 53116 - 53125.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. W. Edmunds and L. C. Mahadevan
MAP kinases as structural adaptors and enzymatic activators in transcription complexes
J. Cell Sci., August 1, 2004; 117(17): 3715 - 3723.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. M. Weber, J.-M. Chen, and S. M. Levitz
Inhibition of Mitogen-Activated Protein Kinase Signaling by Chloroquine
J. Immunol., May 15, 2002; 168(10): 5303 - 5309.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. A. Barber, L. Bruett, B. R. Douglass, D. S. Herbst, M. C. Zink, and J. E. Clements
Visna Virus-Induced Activation of MAPK Is Required for Virus Replication and Correlates with Virus-Induced Neuropathology
J. Virol., January 15, 2002; 76(2): 817 - 828.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. S. Kristof, J. Marks-Konczalik, and J. Moss
Mitogen-activated Protein Kinases Mediate Activator Protein-1-dependent Human Inducible Nitric-oxide Synthase Promoter Activation
J. Biol. Chem., March 16, 2001; 276(11): 8445 - 8452.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. M. Krishna Rao
MAP kinase activation in macrophages
J. Leukoc. Biol., January 1, 2001; 69(1): 3 - 10.
[Abstract] [Full Text]


Home page
J Biol ChemHome page
J. R. Biggs and A. S. Kraft
The Role of the Smad3 Protein in Phorbol Ester-induced Promoter Expression
J. Biol. Chem., December 24, 1999; 274(52): 36987 - 36994.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
F. Ciacci-Woolwine, P. F. McDermott, and S. B. Mizel
Induction of Cytokine Synthesis by Flagella from Gram-Negative Bacteria May Be Dependent on the Activation or Differentiation State of Human Monocytes
Infect. Immun., October 1, 1999; 67(10): 5176 - 5185.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. S. Kristof, J. Marks-Konczalik, and J. Moss
Mitogen-activated protein kinases mediate AP-1-dependent human inducible nitric oxide synthase promoter activation
J. Biol. Chem., December 8, 2000; (2000) 9563200.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1998 by the American Association of Cancer Research.